0, corresponding a concentration of 1 × 108 UFC mL−1 (5 × 108 UFC

0, corresponding a concentration of 1 × 108 UFC mL−1 (5 × 108 UFC at final volume). These cells were centrifuged for 6 min at 1200 rpm and the sediment was resuspended in 5 mL of phosphate buffered saline (PBS) and equalized to a concentration of 1 × 106 UFC

at final volume for virulence and immunomodulatory assays [63]. In vivo experiments were performed with 6–10 weeks old female BALB/c mice from University Volasertib supplier of Campinas (Campinas/SP). Mice were housed and used in accordance with guidelines established by the Ethical Committee of Animal Use of University of Brasília (Brasilia/DF), registered under protocol number UnBDOC:83931/2011, and all efforts were made to minimize animal suffering. Mice were divided into 5 groups of 5 animals each ( Table 1). As described above, groups were infected via intraperitoneal (IP) injection with E. coli suspension equalized and diluted in cold PBS to a sub lethal concentration of 1 × 105 UFC (50 μL

in each animal) [54]. Treatments of infected mice were performed with Pa-MAP at 1 and 5 mg kg−1, both dissolved in 100 μL of PBS, respectively. PBS was utilized as the negative control, and ampicillin at 2 mg kg−1 dissolved in 100 μL of PBS was utilized as the positive control. Moreover, an uninfected control was also performed. All mice were housed with constant water and food in an air-filtered environment maintained at 20 ± 2 °C during 72 h and further treated as described above ( Table 1). Treatments occurred 24 h and 48 h after infection. Moreover, all mice were weighed at the beginning selleck compound and at the end of the experiment. Mice were anesthetized by xilazine and ketamine

at 10 mg kg−1 and 50 mg kg−1, respectively, after 72 h. Blood collection was performed by decapitation and serum obtained by centrifugation during and stored at −20 °C. The cytokines interleukin-10 (IL-10), IL-12, interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), and nitric oxide (NO) were measured in serum by enzyme-linked immunosorbent assays (ELISA) using ELISA kit (Peprotech) according to the manufacturer’s instructions. The statistical significance of the experimental results was determined by one-way Student’s t-test or one-way analysis of variance (ANOVA) followed by Dunnett’s test. Values of P < 0.05 were considered statistically significant. Graphpad Prism version 6.0 was used for all statistical analyses. MALDI-ToF evaluation showed an ion with an m/z of 2212.86, corresponding to the calculated value for the peptide sequence, above 95% in purity. All further bioassays were performed using purified Pa-MAP ( Fig. 1A). In order to confirm the in vitro protective effects of Pa-MAP against E. coli, in vivo antibacterial activity was evaluated by a sub-lethal E. coli mice IP infection. Two concentrations of Pa-MAP (1 mg kg−1 and 5 mg kg−1) treatment were tested. Ampicillin at 2 mg kg−1 was used as a positive control.

Comments are closed.